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ABSTRACT
Objective: We conducted a retrospective 4-year study of
patients undergoing laparoscopic cholecystectomy at a
freestanding ambulatory surgery center. Data on rates of
hospital admission, conversion to open surgery, bile duct
injury, postoperative bile leakage, and incidence of cho-
ledocholithiasis were analyzed. The success rate for dy-
namic fluoroscopic intraoperative cholangiography was
computed, and outpatient laparoscopic common bile duct
exploration and anesthetic management were reviewed.
Methods: Patient charts from the ambulatory surgery cen-
ter, office, and hospital were reviewed over a 4-year period
commencing in October 1999. All cases were performed by
1 of 3 surgeons who are experienced with outpatient lapa-
roscopic cholecystectomy and practice routine dynamic flu-
oroscopic intraoperative cholangiography.
Results: A total of 338 laparoscopic cholecystectomies
were performed. Dynamic fluoroscopic intraoperative
cholangiography was successfully performed in 89%
(n302). No instances of bile duct injury or conversions to
open surgery were reported. A 0.89% (n 3) incidence of
postoperative bile leak occurred. Six patients were admit-
ted for inpatient care for a rate of 1.78%. Choledocholithi-
asis occurred in 2.0% and was managed successfully in the
ambulatory setting.
Conclusion: Laparoscopic cholecystectomy can be
adapted to the freestanding ambulatory surgery environ-
ment with very high standards of care and very low
complication rates.
Key Words: Ambulatory surgery, Cholangiogram, Chole-
docholithiasis, Laparoscopic cholecystectomy, Laparo-
scopic common bile duct exploration.
INTRODUCTION
Laparoscopic cholecystectomy (LC) has become the stan-
dard therapy for symptomatic cholelithiasis. The outpa-
tient management of elective cases has become common
in many institutions. This trend has been driven by the
significant cost savings that have been documented when
outpatient LC is compared with the cost of inpatient care.
Despite this trend, Medicare has not approved LC in free-
standing ambulatory surgical centers (ASC). Some private
insurance companies following the lead of Medicare do
not cover LC in freestanding ASC. Pennsylvania has at-
tempted to curtail LC in freestanding ASC citing safety
concerns. There is very little data in the literature regard-
ing LC in freestanding ASC. A Medline search found only
2 small series of 55 and 66 patients reported.1,2 Our study
reviews a 4-year retrospective series of 338 patients oper-
ated on for elective LC in a freestanding ASC. Routine
dynamic fluoroscopic intraoperative cholangiography
(DFIOC) was performed, because this has been docu-
mented in several studies to reduce the incidence of bile
duct injuries.3,4 Routine DFIOC also allows the detection
of common bile duct (CBD) stones. These may be dealt
with by concurrent laparoscopic common bile duct explo-
ration (LCBDE) at the same time as LC. LCBDE has been
shown in controlled studies to be as effective as or supe-
rior to endoscopic retrograde cholangiopancreatography
(ERCP) for the treatment of choledocholithiasis.5 LCBDE
at the same time as LC has been shown to be the most
cost-effective approach to treating choledocholithiasis.6
Our experience with LCBDE in a freestanding ASC is
reviewed. The frequency of hospital admission after LC at
a freestanding ASC and rates of conversion from LC to
open cholecystectomy are calculated. Further, the cost of
outpatient LC at a full service community hospital is com-
pared with the cost at the freestanding ambulatory center.
METHODS
Patient Demographics
A 4-year retrospective review of all patients undergoing
LC from October 1999 to December 2003 at the Center for
Ambulatory Surgery and Endoscopy of Southeastern New
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SCIENTIFIC PAPERMexico (CASE of NM) was undertaken. Of the 338 patients
in this study, 80% (n272) were female, 20% (n66) were
male. The average age of female patients was 42, and the
average age of male patients was 48. Because patients on
Medicare were not included in this group (LC is not
included on Medicare’s list of covered procedures at an
ASC), our patients tended towards a younger age. LC was
performed electively and preoperative evaluation was
completed at a prior office visit.
ASA Status
ASA Class I patients comprised 15% (n50), ASA Class II
79% (n266), and the remaining 6% (n21) were consid-
ered ASA Class III. No patients were above ASA Class III.
Anesthesia was provided by certified registered nurse
anesthetists.
Procedure
All patients were operated on by 1 of 3 experienced
attending surgeons performing LC at the ASC during this
time frame. All surgeons practiced routine DFIOC and
used a standard 4-port laparoscopic technique. A 10-mm
port was placed at the umbilicus, a second 10-mm port in
the epigastrium, and two 5-mm ports on the right side
(one in the subcostal position in the anterior axillary line
and the second at the level of the umbilicus). DFIOC was
accomplished using the Arrow-Karlan laparoscopic
cholangiography balloon catheter (Arrow International,
Inc. Reading, PA) and the American Catheter guide. The
technique has been described in detail.7 Laparoscopic
cautery scissors were used for dissection. When chole-
docholithiasis was discovered, LCBDE was carried out
using both transcystic duct and choledochotomy ap-
proaches. The Multiple Instrument Guide (MIG) (Lapsur-
gical Systems, LLC, Roswell, NM) was used in conjunction
with the 2.8-mm flexible Olympus choledochoscope
(Olympus Corporation, Melville, NY). The use of the MIG
for LCBDE has been previously described in detail.8
Anesthetic Technique
Surgery was performed with the patients under general
endotracheal anesthesia (GETA) with controlled ventila-
tion and muscle relaxation. Standard monitoring was used
for all patients: noninvasive blood pressure, EKG, Sa02,
and temperature. An orogastric tube was placed only if the
stomach was noted by the surgeon to be distended. An-
esthesia was induced with propofol in all patients and
maintained with oxygen in air and desflurane or sevoflu-
rane. Residual neuromuscular block was reversed at the
end of the procedure.
Rofecoxib (Vioxx) 50mg was given to patients preopera-
tively. Intraoperatively, all patients received opiates,
sufentanil (64%), and fentanyl (33%) and nonopiate ad-
juncts like ketorolac. Intraoperatively, the incision site was
infiltrated with bupivacaine 0.5% or ropivacaine 0.5%.
Patients were given supplemental narcotic (fentanyl) in
the PACU as needed. Hydrocodone or oxycodone was
prescribed for pain after discharge except in patients al-
lergic to the drugs or their known side effects.
Postoperative nausea and vomiting (PONV) prophylaxis
was given to 75% of our patients intraoperatively. Meto-
clopramide, droperidol, ondansetron, or dolasetron, or a
combination of these was administered as prophylaxis for
PONV. Occasional patients were sent home with
promethazine suppositories.
As with all ASC, we require a responsible adult to escort
the patient home after the procedure and to be present the




The excised gallbladder was sent to the pathology labo-
ratory and examined. The resulting diagnoses were taken
from the pathology report. Percentage of patients exhib-
iting chronic cholecystitis with cholelithiasis was 70%
(n234), patients exhibiting chronic cholecystitis was
17% (n56), and patients diagnosed with cholesterolosis
was 6% (n  20). Acute cholecystitis with cholelithiasis
was found in 4% (n15) of patients. The remaining 3%
(n10) were judged to have normal gallbladders.
Dynamic Fluoroscopic Intraoperative
Cholangiography
DFIOC was successfully completed in 89% (n302) of
these patients. Failure to achieve an adequate DFIOC was
often the result of extremely small cystic duct diameter,
being less than the diameter of the cholangiography cath-
eter. In these cases, careful dissection and attention to
anatomic detail (critical view) was relied upon exclu-
sively. This DFIOC technique has not been plagued by
false-positive results leading to unnecessary bile duct ex-
ploration.
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The incidence of bile duct injury was 0% (n0) in this
study, a value we attribute to surgeon experience, careful
dissection, and routine DFIOC.
Postoperative Bile Leakage
The incidence of postoperative bile leakage was 0.9%
(n3). One of these leaks was felt to have originated from
the Duct of Luschka and was treated with catheter drain-
age. The second leak occurred in a patient who went
skiing 2 weeks postoperatively and fell. Adherent omen-
tum pulled eschar off the gallbladder fossa, and this re-
sulted in a bile leak. This presented with intense right
subcostal pain. Diagnostic laparoscopy revealed the prob-
lem. This was treated with a JP drain, and recovery was
uneventful. The third leak occurred in a patient undergo-
ing LCBDE and is discussed further below.
Incidence of Choledocholithiasis
Choledocholithiasis was detected in 2% (n7) of patients
and was successfully managed using LCBDE techniques.
One transcystic duct LCBDE and 6 choledochotomy LCB-
DEs were used. The MIG was used in 5 of these cases to
facilitate stone extraction. Within this choledochotomy
group, a T-tube was placed in 3 patients, and primary
closure was achieved in the other 3. Successful stone
clearance was achieved in 100% (n7) of these patients,
and the patients were allowed to return home that same
day. One patient that had the choledochotomy closed
primarily required hospital admission and laparoscopic
placement of a T-tube, as the choledochotomy closure
leaked, and the JP drain did not prevent bile peritonitis.
Operative Time
Median operative time for LC with routine DFIOC was 46
minutes (mean, 51), with a range from 25 to 230 minutes.
The small number (n10) of cases with operative time
greater than 100 minutes were often dual procedures, in
which another patient problem (hernia and others) was
corrected at the same time as the LC was performed. In
cases with choledocholithiasis, median operative time for
LC with DFIOC and LCBDE was 134 minutes (mean, 120
minutes), with a range from 63 to 208 minutes.
Anesthesia
No primary admissions or readmissions were necessary
because of anesthesia-related complications, difficulty in
controlling pain or PONV. The mean length of stay in the
PACU was 80.1 minutes; the median time was 70 minutes.
Hospital Admission
Percentage of patients requiring admission to the hospital
was 1.78% (n6). The first experienced pleuritic chest
pain. Admission was necessary to rule out pulmonary
embolism. The second developed pancreatitis 12 days
postoperatively. This was one of the patients in whom
DFIOC was not achieved. The third was a diabetic patient
who developed a subhepatic abscess postoperatively and
was treated by placement of a percutaneous drain. The
fourth and fifth patients developed postop bile accumu-
lations. The fourth from a Duct of Luschka leak and the
fifth from trauma secondary to a fall while skiing. These
leaks were treated by placement of a drainage catheter in
the subhepatic space. The sixth was among the patients
who underwent LCBDE. This patient developed a bile
leak after the choledochotomy was closed primarily. The
closure was not watertight and had not been checked by
cystic duct injection. We have since adapted our tech-
niques to include the use of cholangiography and cystic
duct injection while observing the choledochotomy clo-
sure to ensure a watertight seal. This patient required
hospital admission and laparoscopic insertion of a T-tube
to remedy this problem. The Jackson-Pratt peritoneal
drain in the subhepatic space did not prevent bile perito-
nitis from developing in this patient.
Safety
There was a 0% rate of conversion to open surgery, ne-
cessity for blood transfusion, or death in this study.
DISCUSSION
LC in a freestanding ASC has been demonstrated to be safe
and cost-effective. LC is a proven technique that has been
used for over 15 years. Conversion of LC to open chole-
cystectomy in this select group of elective patients should
be a rare event in the hands of qualified surgeons.
Pain control is a major factor affecting the ability of a
patient to go home on the same day. Rofecoxib (Vioxx)
was chosen to be given preoperatively because of a long
half-life (17 hours) permitting once a day dosing and its
effectiveness as an analgesic for postoperative pain. As a
selective COX 2 inhibitor, it has no effect on platelet
function and does not increase the risk of bleeding. It
decreases postoperative narcotic analgesic requirement
and thereby decreases nausea while improving activity
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cardiac complications that occur after 13 months of
chronic usage) is felt to be a significant loss of a valuable
nonnarcotic analgesic that was very useful in relieving
acute postoperative pain.
PONV can be a significant problem after the LC proce-
dure. Relieving PONV is a major determinant of patient
satisfaction. The overall incidence of PONV is 44%/22% in
LC patients treated with placebo antiemetics. The inci-
dence in those treated with metoclopramide is 32%/8%
and with ondansetron is 45%/4%.10 Our numbers for
PONV (4%/1%) are lower than those in most studies
reviewed. Several reasons for this could be hypothesized:
our data are limited to the predischarge period, our mul-
timodality approach to PONV may be very effective, or
PACU nurses may not have documented PONV data rig-
orously in this retrospective study. Another reason may be
that propofol was used as an induction agent. Propofol is
desirable as an induction agent because of its antiemetic
properties and because of its association with more rapid
awakening and discharge.11
Opioids enhance the tendency to PONV and cause spasm
of the Sphincter of Oddi. The latter may create a false
impression of gallstones impacted in the CBD during
cholangiography. When short-acting narcotics are used in
modest doses at induction, the effects may regress by the
time cholangiography is performed.12 It is worthwhile to
use nonopioid analgesics like ketorolac before cholan-
giography to limit the use of opioids. A multimodal ap-
proach to pain works well, ie, local infiltration of the
wound and IV opiates and nonopiates.
In the attempt to make LC as safe as possible, we believe
that routine DFIOC is a vital step in all LC procedures. A
cohort analysis of Medicare patients undergoing cholecys-
tectomy from 1992 through 1999 showed that not using an
IOC during cholecystectomy was associated with a 50-fold
to 70-fold increase in CBD injury.3 A previous study of
ours has shown routine DFIOC adds an average of 4.3
minutes to the LC procedure, an increase in time well
worth the information gained.7
Hospital admission after outpatient LC in our freestanding
ASC is uncommon (1.78%). The complications seen in this
study would likely not be different had these patients
been treated in a hospital-associated surgical facility. We
do not feel that these patients’ care was adversely affected
by treatment in a freestanding ASC. In our study group, we
did not deal with cases of gallstone pancreatitis. Gallstone
pancreatitis has been shown to be a predictor of hospi-
talization, and these patients should be treated in an
inpatient facility.13 Though we did not include Medicare
patients in this study, previous studies have demonstrated
that age is not a significant contraindication to successful
outpatient LC, and that the procedure can be performed
successfully and safely in an unselected population of
patients.13,14
Bile duct leaks occurred after elective LC in this study at a
rate of 0.9%. The leak rate of 1/338 (0.29%) from Ducts of
Luschka draining directly from the liver into the gallblad-
der through the gallbladder bed is comparable to rates
mentioned in the literature.15,16 These can occasionally be
seen during the course of dissection and if identified
should be clipped. The leak secondary to a fall while
skiing in the early postoperative period perhaps should
speak to the need to instruct patients to avoid contact
sports for a more prolonged period of time.
Choledocholithiasis is rare in patients who would be se-
lected for treatment at a freestanding ASC. However, cho-
ledocholithiasis is likely to be detected in about 2% of
these patients, based on this study. These may be dealt
with by a trained laparoscopic surgeon in an outpatient
environment. Outpatient LCBDE is a feasible, effective
treatment, as demonstrated by our 100% stone clearance
rate. LCBDE at the time of LC precludes the need for pre-
or postoperative ERCP and its approximate 10% risk of
pancreatitis, which will be severe in about 1% of cases in
which it develops.17–19
The cost savings for the patient at a freestanding ASC is
significant. The cost of outpatient LC at our freestanding
ASC is between $4,000 and $6,000. The cost for the same
procedure (outpatient LC) at our local hospital is between
$16,000 and $17,000.
CONCLUSION
We can identify no medical or safety issue that would
explain why Medicare should not allow outpatient LC to
be performed at a freestanding ASC. By failing to allow the
choice of surgical venue, Medicare patients are forced to
pay considerably higher costs for a level of care that has
not been demonstrated to be safer than that of a freestand-
ing ASC. Age not being a significant predictor of compli-
cations, choice of surgical venue should be between sur-
geon and patient. We feel that any healthy patient not
deemed to be at high risk for complications should be
given the option to be treated in a freestanding ASC for
safe, effective care at a reasonable cost.
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